These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15453288)

  • 1. [HBV-specific immune response in hepatocyte destruction].
    Saibara T; Iwasaki S
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():66-9. PubMed ID: 15453288
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B virus sensitizes hepatocytes to complement-dependent cytotoxicity through downregulating CD59.
    Qu Z; Liang X; Liu Y; Du J; Liu S; Sun W
    Mol Immunol; 2009 Dec; 47(2-3):283-9. PubMed ID: 19804910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD95/CD95 ligand-mediated counterattack does not block T cell cytotoxicity.
    Jekle A; Obst R; Lang F; Rammensee HG; Gulbins E
    Biochem Biophys Res Commun; 2000 Jun; 272(2):395-9. PubMed ID: 10833425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes.
    Barnaba V; Franco A; Alberti A; Benvenuto R; Balsano F
    Nature; 1990 May; 345(6272):258-60. PubMed ID: 2110296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of non-MHC-restricted cytotoxicity in a patient with pure red cell aplasia: functional relevance to antigen-specific cytotoxic T cells.
    Morikawa K; Oseko F; Hara J; Morikawa S
    Hematol Pathol; 1991; 5(3):125-38. PubMed ID: 1960136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBV genes induce cytotoxic T-lymphocyte response upon adeno-associated virus (AAV) vector delivery into dendritic cells.
    You H; Liu Y; Cong M; Ping W; You C; Zhang D; Mehta JL; Hermonat PL
    J Viral Hepat; 2006 Sep; 13(9):605-12. PubMed ID: 16907847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus replication could enhance regulatory T cell activity by producing soluble heat shock protein 60 from hepatocytes.
    Kondo Y; Ueno Y; Kobayashi K; Kakazu E; Shiina M; Inoue J; Tamai K; Wakui Y; Tanaka Y; Ninomiya M; Obara N; Fukushima K; Ishii M; Kobayashi T; Niitsuma H; Kon S; Shimosegawa T
    J Infect Dis; 2010 Jul; 202(2):202-13. PubMed ID: 20533879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethanol attenuates presentation of cytotoxic T-lymphocyte epitopes on hepatocytes of HBV-infected humanized mice.
    Ganesan M; Wang W; Mathews S; Makarov E; New-Aaron M; Dagur RS; Malo A; Protzer U; Kharbanda KK; Casey CA; Poluektova LY; Osna NA
    Alcohol Clin Exp Res; 2022 Jan; 46(1):40-51. PubMed ID: 34773268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide-beta2-microglobulin-major histocompatibility complex expressing cells are potent antigen-presenting cells that can generate specific T cells.
    Obermann S; Petrykowska S; Manns MP; Korangy F; Greten TF
    Immunology; 2007 Sep; 122(1):90-7. PubMed ID: 17472719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of indoleamine 2,3-dioxygenase in hepatocyte during acute hepatitis caused by hepatitis B virus-specific cytotoxic T lymphocytes in vivo.
    Iwamoto N; Ito H; Ando K; Ishikawa T; Hara A; Taguchi A; Saito K; Takemura M; Imawari M; Moriwaki H; Seishima M
    Liver Int; 2009 Feb; 29(2):277-83. PubMed ID: 18397228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative immunogenicity of hepatitis B virus-encoded antigens as targets for cytotoxic T-cell response.
    Ishikawa T; Kakumu S; Yoshioka K; Yamada M; Tanaka K; Higashi Y; Takayanagi M; Okumura A; Kojima A; Tamura T
    Immunology; 1993 Oct; 80(2):313-8. PubMed ID: 8262560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HCV-specific cytotoxic T lymphocyte and its epitope].
    Morita H; Imawari M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):155-8. PubMed ID: 15359784
    [No Abstract]   [Full Text] [Related]  

  • 13. [Recent advance in the study of immunopathobiology of hepatitis B virus infection using HBV transgenic mice].
    Kakimi K
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():54-7. PubMed ID: 15453285
    [No Abstract]   [Full Text] [Related]  

  • 14. Manifestation of the MHC-unrestricted killing potential of a cytotoxic T cell clone requires activation in response to MHC-restricted self-presentation of antigen.
    Dick T; Staege MS; Reichmann G; Reske-Kunz AB
    J Immunol; 1993 Apr; 150(7):2575-83. PubMed ID: 8454844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
    Zhou C; Peng G; Jin X; Tang J; Chen Z
    Clin Immunol; 2010 Nov; 137(2):190-8. PubMed ID: 20692873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: hepatocyte-expressed membrane-bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in rats.
    Scherer MN; Graeb C; Tange S; Dyson C; Jauch KW; Geissler EK
    Hepatology; 2000 Nov; 32(5):999-1007. PubMed ID: 11050050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of the CD8 antigen on cytotoxic human T cells in response to phorbol myristate acetate or antigen-presenting B cells.
    Acres RB; Conlon PJ; Mochizuki DY; Gallis B
    J Immunol; 1987 Oct; 139(7):2268-74. PubMed ID: 3116077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy.
    Noy R; Eppel M; Haus-Cohen M; Klechevsky E; Mekler O; Michaeli Y; Denkberg G; Reiter Y
    Expert Rev Anticancer Ther; 2005 Jun; 5(3):523-36. PubMed ID: 16250828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Variation in HBV antigen presentation with HLA typing and course of hepatitis B virus infection].
    Manabe K
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():79-83. PubMed ID: 15453291
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunology. The ins and outs of antigen processing and presentation.
    Germain RN
    Nature; 1986 Aug 21-27; 322(6081):687-9. PubMed ID: 3489186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.